Our findings that uPAR modulates signals promoting survival and proangiogenic properties of c-kit+ MPCs suggest that targeting this receptor is reasonable for overcoming the problems of poor survival and engraftment of transplanted cells, which could have significant prospects for the development of regenerative technologies for heart diseases. This evidence concerns the gene KIT and heart disorder.